Expanded Access: Past, Present and Future Improvements

Additional Concepts, Closeout, EAP, Execution, Forecasting / Planning

Expanded access is a program that provides patients with investigational medicinal products (IMP) for treatment purposes. These patients are often excluded from clinical trials but could still benefit from access to the drugs, biologics or medical devices being tested. While, in concept, expanded access represents a way to help more patients receive new and developing treatments, in reality, the process is complex and often misunderstood.

Download Position Paper

Related Education Resources.

All Resources

2023 EKF Workshop - Getting Clinical Trial Supplies a Seat at the Table

Topics: EKF - 2023, Project Management

Presentation

Members

Lessons Learned: Conducting COVID Clinical Trials and Building a Clinical Supplies Team During the Peak of the Pandemic

Topics: Conference, COVID-19

Executive Summary

Members

COVID-19’s Impact on the Supply Chain in Asia-Pacific

Topics: COVID-19, Supply Chain

Webinar

Free

Become a member

Global Clinical Supplies Group

Join GCSG for full access...

to our educational resources, conference materials and our directory of more than 480 Clinical Supply colleagues. Experience the culture of collaboration, It only takes approximately 3 minutes 22 seconds.

Please note that membership is included and FREE of charge when you sign up for an event.